Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001636178-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-15 | UTHR | EDGEMOND JAMES | CFO AND Treas | F - Tax | $536.12 | -8,786 | 18.9K | -32% | -$4.71M |
| DM | 2026-03-17 | 2026-03-15 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | — | +19.5K | 27.7K | +238% | — |
| DM | 2026-03-17 | 2026-03-15 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $0.00 | -19.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | F | D | 4,682 | $536.12 | 22,980 | D | — | — | (F3) Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. |
| 2 | Common | Common Stock | 2026-03-15 | M | A | 10,380 | — | 18,564 | D | — | — | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F2) Includes 42 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2026-03-15 | M | A | 9,098 | — | 27,662 | D | — | — | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. |
| 4 | Common | Common Stock | 2026-03-15 | F | D | 4,104 | $536.12 | 18,876 | D | — | — | (F3) Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. |
| 5 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 9,098 | $0.00 | 0 | D | — · — to — | 9,098 Common Stock | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F4) Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023. |
| 6 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 10,380 | $0.00 | 0 | D | — · — to — | 10,380 Common Stock | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F4) Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023. |